Allergy and Immunology · Bronx, NY
NPI
1225119647
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Montefiore Medical Park, 1515 Blondell Avenue, Ste. 220
Bronx, NY, 10461
Phone (866) 633-8255
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
1,163 services
Medicare patients, 2024
63
Average age 68
Drug cost, 2024
$2.5M
3,976 prescriptions
Company payments, 2025
$2,638
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Golda Hudes was code 95004 (test - miscellaneous), 518 times for 12 patients. In total Golda Hudes billed 1,163 services in 14 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 518 | 12 | $3.89 | $2,015 |
| 99213 Office E&M - Established | Office | 37 | 24 | $61.16 | $2,263 |
| 99213 Office E&M - Established | Facility | 32 | 20 | $57.45 | $1,838 |
| 99214 Office E&M - Established | Office | 18 | 14 | $93.74 | $1,687 |
| 99212 Office E&M - Established | Office | 12 | 11 | $37.72 | $453 |
By year: 2022 $14K for 1,119 services; 2023 $13K for 1,133 services; 2024 $15K for 1,163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Golda Hudes prescribed most often to Medicare patients was Fluticasone Propionate, with 667 prescriptions and refills. In total Golda Hudes wrote 3,976 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 667 | 814 | 166 | $5,936 |
| Azelastine Hcl Generic | 322 | 367 | 78 | $4,096 |
| Montelukast Sodium Generic | 311 | 443 | 83 | $2,148 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 249 | 270 | 79 | $8,479 |
| Prednisone Generic | 214 | 218 | 86 | $744 |
| Xolair Omalizumab | 177 | 180 | 23 | $512K |
| Triamcinolone Acetonide Generic | 142 | 165 | 57 | $2,017 |
| Dupixent Syringe Dupilumab | 135 | 144 | 24 | $512K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 133 | 157 | 26 | $95K |
| Hydroxyzine Hcl Generic | 133 | 143 | 34 | $1,195 |
| Dupixent Pen Dupilumab | 107 | 107 | 16 | $384K |
| Breo Ellipta Fluticasone/Vilanterol | 103 | 110 | 21 | $40K |
| Nucala Mepolizumab | 64 | 64 | Under 11 | $318K |
| Azithromycin Generic | 60 | 60 | 30 | $483 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 57 | 60 | 15 | $6,166 |
Brand drugs: 1,402 claims; generic drugs: 2,574 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Golda Hudes $2,638 ($297 in general payments such as food, travel and fees and $2,340 for research) from 6 companies. The largest payer was GlaxoSmithKline, LLC. with $2,448.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.